Get notified when IMVT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsImmunovant reports Q4 and fiscal year 2026 financial results
Filed May 20, 2026 · Period ending May 20, 2026 · ~1 min read
Key Changes
-
medium
Company issued press release announcing financial results for fourth quarter and full fiscal year ended March 31, 2026. Actual figures are in the attached exhibit, not the 8-K body.
Item 2.02 verify on EDGAR → -
low
This is a routine earnings announcement filing. The 8-K itself contains no financial data—investors must review the press release exhibit for performance details.
8-K: Earnings verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.
Partner
Trade IMVT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · May 25, 2026 · How we verify